First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — Financial Flexibility Index
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Financial Flexibility Index of -0.98x as of March 2026. Free cash flow of $-32.54 Million (operating CF $-32.56 Million minus capex $17.00K) represents -1% of total liabilities ($33.11 Million). Check asset allocation strategy of First Tracks Biotherapeutics, Inc. Ordin to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Financial Flexibility Index (2023–2024)
Historical Financial Flexibility Index trend for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued across 2 annual periods. See working capital position of First Tracks Biotherapeutics, Inc. Ordin to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
Year-by-year free cash flow to debt coverage for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued. For the full company profile including market capitalisation, see TRAXV company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.49x | $-125.45 Million | $-125.81 Million | $50.30 Million | ▲ +7.3% |
| 2023 | -2.69x | $-92.20 Million | $-93.00 Million | $34.26 Million | — |